Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 75

1.

The effect of lymphadenectomy and radiotherapy on recurrence and survival in endometrial carcinoma. Experience in a population reference centre.

Arenas M, Gascón M, Rovirosa À, Hernández V, Riu F, López I, Montero A, Sabater S.

Rep Pract Oncol Radiother. 2014 Oct 14;20(1):50-6. doi: 10.1016/j.rpor.2014.09.003. eCollection 2015 Jan.

2.

Ten-year data on 138 patients with endometrial carcinoma and postoperative vaginal brachytherapy alone: no need for external-beam radiotherapy in low and intermediate risk patients.

Röper B, Astner ST, Heydemann-Obradovic A, Thamm R, Jacob V, Hölzel D, Schmalfeldt B, Kiechle-Bahat M, Höss C, Molls M.

Gynecol Oncol. 2007 Dec;107(3):541-8. Epub 2007 Sep 20.

PMID:
17884152
3.

The impact of age on long-term outcome in patients with endometrial cancer treated with postoperative radiation.

Jolly S, Vargas CE, Kumar T, Weiner SA, Brabbins DS, Chen PY, Floyd W, Martinez AA.

Gynecol Oncol. 2006 Oct;103(1):87-93. Epub 2006 Mar 20.

PMID:
16545441
4.

High-risk surgical stage 1 endometrial cancer: analysis of treatment outcome.

Viani GA, Patia BF, Pellizzon AC, De Melo MD, Novaes PE, Fogaroli RC, Conte MA, Salvajoli JV.

Radiat Oncol. 2006 Aug 3;1:24.

5.

Lymphadenectomy in women with endometrial cancer: aspiration and reality from a radiation oncologist's point of view.

Foerster R, Kluck R, Arians N, Rieken S, Rief H, Adeberg S, Bostel T, Schlampp I, Debus J, Lindel K.

Radiat Oncol. 2015 Jul 16;10:147. doi: 10.1186/s13014-015-0460-2.

6.

Lymph-vascular space involvement and outer one-third myometrial invasion are strong predictors of distant haematogeneous failures in patients with stage I-II endometrioid-type endometrial cancer.

Gadducci A, Cavazzana A, Cosio S, DI Cristofano C, Tana R, Fanucchi A, Teti G, Cristofani R, Genazzani AR.

Anticancer Res. 2009 May;29(5):1715-20.

7.

Postoperative radiotherapy in endometrial carcinoma: analysis of prognostic factors in 440 cases.

Yalman D, Ozsaran Z, Anacak Y, Celik OK, Ozkök S, Ozsaran A, Hanhan M, Haydaroğlu A.

Eur J Gynaecol Oncol. 2000;21(3):311-5.

PMID:
10949404
8.

Outcome after salvage radiotherapy (brachytherapy +/- external) in patients with a vaginal recurrence from endometrial carcinomas.

Hasbini A, Haie-Meder C, Morice P, Chirat E, Duvillard P, Lhommé C, Delapierre M, Gerbaulet A.

Radiother Oncol. 2002 Oct;65(1):23-8.

PMID:
12413671
9.

Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma.

Creutzberg CL, van Putten WL, Koper PC, Lybeert ML, Jobsen JJ, Wárlám-Rodenhuis CC, De Winter KA, Lutgens LC, van den Bergh AC, van de Steen-Banasik E, Beerman H, van Lent M.

Lancet. 2000 Apr 22;355(9213):1404-11.

PMID:
10791524
10.

Improved outcome in patients treated with postoperative radiation therapy for pathologic stage I/II endometrial cancer.

Algan O, Tabesh T, Hanlon A, Hogan WM, Boente M, Lanciano RM.

Int J Radiat Oncol Biol Phys. 1996 Jul 15;35(5):925-33.

PMID:
8751401
11.

Adenocarcinoma of the endometrium treated with combined irradiation and surgery: study of 437 patients.

Touboul E, Belkacémi Y, Buffat L, Deniaud-Alexandre E, Lefranc JP, Lhuillier P, Uzan S, Jannet D, Uzan M, Antoine M, Huart J, Ganansia V, Milliez J, Blondon J, Housset M, Schlienger M.

Int J Radiat Oncol Biol Phys. 2001 May 1;50(1):81-97.

PMID:
11316550
12.

The significance of the amount of myometrial invasion in patients with Stage IB endometrial carcinoma.

Alektiar KM, McKee A, Lin O, Venkatraman E, Zelefsky MJ, Mychalczak BR, McKee B, Hoskins WJ, Barakat RR.

Cancer. 2002 Jul 15;95(2):316-21.

13.

Intravaginal brachytherapy alone for intermediate-risk endometrial cancer.

Alektiar KM, Venkatraman E, Chi DS, Barakat RR.

Int J Radiat Oncol Biol Phys. 2005 May 1;62(1):111-7.

PMID:
15850910
14.

Endometrial adenocarcinoma: an analysis of treatment and outcome.

Byrd LM, Swindell R, Webber-Rookes D, Hannon R, Hunter RD, Livsey J, Davidson SE.

Oncol Rep. 2008 Nov;20(5):1221-8.

PMID:
18949425
15.

Operable Stages IB and II cervical carcinomas: a retrospective study comparing preoperative uterovaginal brachytherapy and postoperative radiotherapy.

Atlan D, Touboul E, Deniaud-Alexandre E, Lefranc JP, Antoine JM, Jannet D, Lhuillier P, Uzan M, Huart J, Genestie C, Antoine M, Jamali M, Ganansia V, Milliez J, Uzan S, Blondon J.

Int J Radiat Oncol Biol Phys. 2002 Nov 1;54(3):780-93.

PMID:
12377330
16.

Ten-year outcome including patterns of failure and toxicity for adjuvant whole abdominopelvic irradiation in high-risk and poor histologic feature patients with endometrial carcinoma.

Stewart KD, Martinez AA, Weiner S, Podratz K, Stromberg JS, Schray M, Mitchell C, Sherman A, Chen P, Brabbins DA.

Int J Radiat Oncol Biol Phys. 2002 Oct 1;54(2):527-35.

PMID:
12243832
17.
18.

[Preoperative concurrent radiation therapy and chemotherapy for operable bulky carcinomas of uterine cervix stages IB2, IIA, and IIB with proximal parametrial invasion].

Lerouge D, Touboul E, Lefranc JP, Uzan S, Jannet D, Moureau-Zabotto L, Genestie C, Antoine M, Jamali M.

Cancer Radiother. 2004 Jun;8(3):168-77. French.

PMID:
15217584
19.

[Postoperative radiotherapy in endometrial carcinoma. A retrospective analysis of 541 cases].

Hänsgen G, Nagel M, Dunst J, Enke H.

Strahlenther Onkol. 1999 Nov;175(11):548-53. German.

PMID:
10584124
20.

[Endometrial adenocarcinoma treated with combined radiotherapy and surgery: 437 cases].

Touboul E, Belkacémi Y, Buffat L, Deniaud-Alexandre E, Lefranc JP, Lhuillier P, Uzan S, Jannet D, Uzan M, Antoine M, Ginesty C, Ganansia V, Jamali M, Milliez J, Blondon J, Schlienger M.

Cancer Radiother. 2001 Aug;5(4):425-44. French.

PMID:
11521391

Supplemental Content

Support Center